
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-
Description
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-2030
The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Vaccine Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló, Inc., Allergy Therapeutics PLC, Angany Inc., Astellas Pharma Inc., Biomay AG, DBV Technologies SA, Enesi Pharma Limited, Immunomic Therapeutics, Inc., Jubilant Pharma Limited, LETI Pharma, S.L.U., Merck & Co., Inc., Novartis AG, Sementis Ltd., Stallergenes Greer International AG, Sunstone by Anergis SA, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Allergy Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:
Allergy Type
Allergic Asthma
Cat Allergy Vaccine
HIV
Homecare
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Allergy Vaccine Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Vaccine Market?
- What are the technology trends and regulatory frameworks in the Allergy Vaccine Market?
- What is the market share of the leading vendors in the Allergy Vaccine Market?
- Which modes and strategic moves are suitable for entering the Allergy Vaccine Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Allergy Vaccine Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of allergies globally
- 5.1.1.2. Increasing air pollution with industrialization
- 5.1.1.3. Rising awareness among consumers about the allergies
- 5.1.2. Restraints
- 5.1.2.1. Limited allergy vaccine manufacturers
- 5.1.3. Opportunities
- 5.1.3.1. Research and development for the production of specific allergy vaccine
- 5.1.3.2. Government and private sector initiatives in the production of vaccines
- 5.1.4. Challenges
- 5.1.4.1. Capital intensive in the production of allergy vaccines
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Allergy Vaccine Market, by Allergy Type
- 6.1. Introduction
- 6.2. Allergic Asthma
- 6.3. Cat Dander Allergy
- 6.4. Grass Pollen Hypersensitivity
- 6.5. Peanut Hypersensitivity
- 6.6. Seasonal Allergic Rhinitis
- 6.7. Tree Pollen Hypersensitivity
- 7. Allergy Vaccine Market, by Vaccine Type
- 7.1. Introduction
- 7.2. Cat Allergy Vaccine
- 7.3. House Dust Mite Allergy Vaccine
- 7.4. Injectable MPL Allergy Vaccine
- 7.5. Peanut Allergy Vaccine
- 7.6. Ragweed Allergy Immunotherapy Vaccine
- 8. Allergy Vaccine Market, by Application
- 8.1. Introduction
- 8.2. HIV
- 8.3. Oncology
- 8.4. Respiratory
- 9. Allergy Vaccine Market, by End User
- 9.1. Introduction
- 9.2. Homecare
- 9.3. Hospitals
- 9.4. Specialty Clinics
- 10. Americas Allergy Vaccine Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Allergy Vaccine Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Allergy Vaccine Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. ALK-Abelló, Inc.
- 14.1.2. Allergy Therapeutics PLC
- 14.1.3. Angany Inc.
- 14.1.4. Astellas Pharma Inc.
- 14.1.5. Biomay AG
- 14.1.6. DBV Technologies SA
- 14.1.7. Enesi Pharma Limited
- 14.1.8. Immunomic Therapeutics, Inc.
- 14.1.9. Jubilant Pharma Limited
- 14.1.10. LETI Pharma, S.L.U.
- 14.1.11. Merck & Co., Inc.
- 14.1.12. Novartis AG
- 14.1.13. Sementis Ltd.
- 14.1.14. Stallergenes Greer International AG
- 14.1.15. Sunstone by Anergis SA
- 14.1.16. Thermo Fisher Scientific Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ALLERGY VACCINE MARKET RESEARCH PROCESS
- FIGURE 2. ALLERGY VACCINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. ALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ALLERGY VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ALLERGY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ALLERGY VACCINE MARKET DYNAMICS
- FIGURE 7. ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
- FIGURE 10. ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. ALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.